Stock Events

Stock Events

Denali Therapeutics (DNLI) Q4 2024 Earnings

6NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.86

-0.77

-0.68

-0.59

Details

Expected EPS

-0.595062

Actual EPS

-0.63

Surprise EPS

-0.03

Surprise Percent

+5.87%

Description

Denali Therapeutics (DNLI) has reported earnings of -0.63 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.